Lexology July 31, 2024
Click here to listen to the audio
On this episode of Non-binding Guidance, hear from Kellie Combs, chair of Ropes & Gray’s life sciences regulatory and compliance practice group, and Josh Oyster, a nationally recognized partner in the life sciences regulatory and compliance practice, as they discuss the FDA’s revised draft guidance, “Addressing Misinformation About Medical Devices and Prescription Drugs: Questions and Answers.” They address key changes from the FDA’s prior draft guidance, potential challenges in implementing the FDA’s recommendations, and how the new guidance fits within the FDA’s overall framework for medical product manufacturer communications.
Transcript:
Kellie Combs: Hello, and welcome to Non-binding Guidance, a podcast series from Ropes & Gray focused on current trends in FDA regulatory law...
Today's Sponsors
Today's Sponsor